Document Detail


The effects of nebulized albuterol on esophageal function in asthmatic patients.
MedLine Citation:
PMID:  18270832     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PURPOSE: Albuterol reduces lower esophageal sphincter (LES) pressure in normal volunteers, although the effects of albuterol on esophageal function in asthmatic patients are not known. The aim of this study was to evaluate the effects of nebulized albuterol on lower esophageal function in asthmatic patients. Symptoms and a methacholine challenge test were used to identify asthmatic patients who were then enrolled in a prospective, randomized, placebo-controlled, double-blinded, crossover trial. Changes in esophageal function in response to nebulized albuterol or placebo were evaluated over two sessions spaced 1 week apart. RESULTS: Albuterol induced a dose-dependent drop in lower esophageal sphincter basal pressure with a threshold dose as low as 2.5 mg. Albuterol did not affect the amplitude of esophageal contractions. CONCLUSIONS: Nebulized albuterol induces a dose-dependent reduction in LES basal pressure in asthmatic patients. These effects raise the possibility that gastroesophageal reflux may occur after bronchodilator therapy.
Authors:
Brian E Lacy; Carole Mathis; John DesBiens; Mark C Liu
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't     Date:  2008-02-13
Journal Detail:
Title:  Digestive diseases and sciences     Volume:  53     ISSN:  0163-2116     ISO Abbreviation:  Dig. Dis. Sci.     Publication Date:  2008 Oct 
Date Detail:
Created Date:  2008-09-01     Completed Date:  2008-10-30     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7902782     Medline TA:  Dig Dis Sci     Country:  United States    
Other Details:
Languages:  eng     Pagination:  2627-33     Citation Subset:  AIM; IM    
Affiliation:
Section of Gastroenterology & Hepatology, Dartmouth-Hitchcock Medical Center, Area 4C, 1 Medical Center Drive, Lebanon, NH 03756, USA, brian.lacy@hitchcock.org
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Albuterol / adverse effects,  pharmacology*,  therapeutic use
Asthma / drug therapy,  physiopathology*
Bronchodilator Agents / adverse effects,  pharmacology*,  therapeutic use
Cross-Over Studies
Dose-Response Relationship, Drug
Double-Blind Method
Esophageal Sphincter, Lower / drug effects*,  physiopathology*
Female
Gastroesophageal Reflux / chemically induced,  physiopathology
Humans
Male
Middle Aged
Nebulizers and Vaporizers
Pressure
Prospective Studies
Chemical
Reg. No./Substance:
0/Bronchodilator Agents; 18559-94-9/Albuterol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Association of gluten enteropathy and irritable bowel syndrome in adult Turkish population.
Next Document:  Is oral L-acyl-carnitine an effective therapy for hepatic encephalopathy? Review of the literature.